BlackRock Health Sciences Term Trust DEFA14A, filed May 14, 2024
BlackRock Health Sciences Term Trust (BMEZ)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
| Filed by the Registrant ☒ | ||
| Filed by a Party other than the Registrant ☐ | ||
| Check the appropriate box: |
||
| ☐ Preliminary Proxy Statement
☐ Definitive Proxy Statement |
☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
| ☒ Definitive Additional Materials | ||
| ☐ Soliciting Material Pursuant to § 240.14a-12 | ||
BLACKROCK HEALTH SCIENCES TERM TRUST
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if Other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ☒ | No fee required. | |
| ☐ | Fee paid previously with preliminary materials. | |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. | |
|
|
... |
We are proud of our 36-year history as a leader and innovator of closed-
end funds. Investors choose BlackRock because of the long-term value we
can provide our fund shareholders over time. We are disappointed that
arbitrage investors are trying to distort and manipulate the purpose of
CEFs to line their pockets at the expense of retail shareholders – the
majority of whom are seeking income over time, not one-time payouts.
1:58 PM • May 14, 2024